Cjs 210 Week 6 Checkpoint

Reactive Patrol CJS/210 January 17, 2012 Michael Catanzarita Reactive Patrol As I read chapter seven â€Å"Patrol and Traffic â€Å", I learn that a reactive patrol is a form of random patrol. Random patrol is said to be incident driven, or reactive, in that officers are responding to crimes only after they occur, either through rapid response to calls for service or to a violation or call in progress. Due to officer constantly moving it makes responding to these 911 calls easier and faster to respond. The specific activities an officer engages in while on random patrol vary significantly across officers, times, locations, and departments, because much of the time spent on patrol is officer initiated (Grant & Terry, 2008). I also learned about proactive patrol which is known as a Directed patrol. A direct patrol focuses more on targeted hot spots, crime problems, and/or offenders. Directed patrol addresses the problem-identification component of the problem solving process (Grant & Terry, 2008). Sometimes a directed patrol can occur on an informal level; this may be when an officer regularly drives past hot spots during random wanderings or parking the squad car in a specific location when writing reports are examples of an informal level. If policing agencies adopted only one of these patrol styles it would be harder to have police discretion. The condition of officer’s reaction to certain responds would change. If there was only reactive patrol officers would never be able to try to stop crimes before they happen. It would be wonderful to be able to stop all crimes before they happen but in all actuality we know this is not possible and that is why we need reactive and proactive patrol to keep our streets safe. Reference Grant, H. B. , & Terry, K. J. (2008). Law Enforcement. Patrol and Traffic, 7(Chapter 7), 171-172.

Alcoholic beverage Essay

? The book ,The History of the World in Six Glasses by Tom Standage is a book dedicated to beverages and there impact on cultures and civilizations. Tom Standage’s intent for this non-fiction novel was to show six insignificant products that we see, use or have heard of in everyday life and bring them into a different light. Showing how they have sculpted our cultures and ways of life in the modern world. These six products were beverages ; beer, wine , spirits, coffee, tea, and coca-cola. These drinks affected more than just the diet of people it changed their societies and ways of living. Standage’s theory is that each one of these drinks brought on a new cultural stage. Each beverage showing different eras and how the beverage of that time impacted their way of life eventually impacting ours. Starting with beer in the first civilizations of Mesopotamia and Egypt. Then going to wine with Greece and Rome and spirits in the colonial times with Europians and eventually getting to America. Next, their was coffee that started in the Arab world traveling throughout Europe and finally Coca-cola which started selling its drink in America and out broke to throughout the rest of world. His intent was to show the history of the world in which humans were not nomadic in the view of six different drinks. Standage presented his thesis in a very interesting and intriguing way throughout this novel. There are six main Chapters in this book ;Beer in Mesopotamia and Egypt, Wine in Greece and Rome,Spirits in the colonial Period, Coffee in the Age of Reason, Tea and the British Empire, and Coca-Cola and the Rise of America. Each main chapter has two mini chapters in them for example in the chapter Tea and the British Empire the two mini chapters are ; Empires of tea and Tea Power. Standage’s writing mostly focased on the beverages causes and effects in the different areas and lands they were most popular and developed but he would add things about the people of these times and their way of living. He also added some traditions that we have in today’s culture that were created in ancient times such as clinking glasses together for good health and happiness before drinking a glass of beer. His book shows how six measly little drinks changed humans from nomadic people who were hunter- gatherers to people who lived in cities and developed writing, government and farming. Standage showed the history of the world in six drinks hence the title A History of the World in Six Glasses. Most everyday people would think these drinks were Sarah Bedell 9/4/14 A. P. World History Mrs. Spampinato The History of the World in Six Glasses : Book Review The book ,The History of the World in Six Glasses by Tom Standage is a book dedicated to beverages and there impact on cultures and civilizations. Tom Standage’s intent for this non-fiction novel was to show six insignificant products that we see, use or have heard of in everyday life and bring them into a different light. Showing how they have sculpted our cultures and ways of life in the modern world. These six products were beverages ; beer, wine , spirits, coffee, tea, and coca-cola. These drinks affected more than just the diet of people it changed their societies and ways of living. Standage’s theory is that each one of these drinks brought on a new cultural stage. Each beverage showing different eras and how the beverage of that time impacted their way of life eventually impacting ours. Starting with beer in the first civilizations of Mesopotamia and Egypt. Then going to wine with Greece and Rome and spirits in the colonial times with Europians and eventually getting to America. Next, their was coffee that started in the Arab world traveling throughout Europe and finally Coca-cola which started selling its drink in America and out broke to throughout the rest of world. His intent was to show the history of the world in which humans were not nomadic in the view of six different drinks. Standage presented his thesis in a very interesting and intriguing way throughout this novel. There are six main Chapters in this book ;Beer in Mesopotamia and Egypt, Wine in Greece and Rome,Spirits in the colonial Period, Coffee in the Age of Reason, Tea and the British Empire, and Coca-Cola and the Rise of America. Each main chapter has two mini chapters in them for example in the chapter Tea and the British Empire the two mini chapters are ; Empires of tea and Tea Power. Standage’s writing mostly focased on the beverages causes and effects in the different areas and lands they were most popular and developed but he would add things about the people of these times and their way of living. He also added some traditions that we have in today’s culture that were created in ancient times such as clinking glasses together for good health and happiness before drinking a glass of beer. His book shows how six measly little drinks changed humans from nomadic people who were hunter- gatherers to people who lived in cities and developed writing, government and farming. Standage showed the history of the world in six drinks hence the title A History of the World in Six Glasses.

Strategic Fit Analysis of Starbucks The United States Segment Assignment

Strategic Fit Analysis of Starbucks The United States Segment - Assignment Example Our global business delivered the highest levels of service to our customers, a truly rewarding experience to our partners (employees), and a record-level performance to shareholders.† (Schultz, 2011). The Starbucks business strategy seeks to address sustainability, maintainability, and growth issues through effective management of available resources while assessing risks, opportunities and threats to ensure a sustainable growth while keeping the company’s value plan intact. The ultimate objective of business strategy is not only to earn good profits but also to win the customer satisfaction and confidence of shareholders and workforce. The Company’s Proxy statement for the year 2012 outlines some of these strategic guidelines in these words, â€Å"The involvement of the board of directors in reviewing Starbucks business strategy is an integral aspect of the board’s assessment of management’s tolerance for risk and also its determination of what co nstitutes an appropriate level of risk for the Company.† (Proxy, 2012). The purpose of the report is to establish a best strategic fit of Starbucks to further strengthen its position and share in the US coffee market. Before finding a best strategic fit for a growing company like Starbucks, it is imperative to explore various internal strengths and weaknesses of company as well as external opportunities and threats that it may face in the regional competitive market. Starbucks has a strategic insight into the growing market of coffee in United States. Ganes-Chase (2012) has explained the reasons towards changing coffee consumption trends for US in a more meaningful manner â€Å"Cof ­fee has had con ­sid ­er ­able pos ­i ­tive media cov ­er ­age about stud ­ies find ­ing drink ­ing cof ­fee to be good for your... The purpose of the report is to establish a best strategic fit of Starbucks to further strengthen its position and share in the US coffee market. Before finding a best strategic fit for a growing company like Starbucks, it is imperative to explore various internal strengths and weaknesses of company as well as external opportunities and threats that it may face in the regional competitive market. Starbucks has a strategic insight into the growing market of coffee in United States. This discussion declares that businesses are not operated in isolation they effects and got effected by Macro and Micro economic factors and forces. A successful business needs to identify the best strategic fit for its products while handling these factors and forces for the sustainability and growth of the business. Starbucks requires a carefully designed strategy to overcome various forces that may have an adverse impact on the business while cashing on the opportunities. The forth coming sections will outline various threats and opportunities posed by the multifaceted macro and micro forces. PESTEL Analysis is an effective macro-environment analytical tool. It may include the investigation of several factors that may effect the business operation of Starbucks in US to help in the decision making process of the business. This analysis will focus economic, political, legal and technological factors.

What is voice Essay Example | Topics and Well Written Essays - 750 words

What is voice - Essay Example But everybody wants to find a way to put off the bully or whoever it is that is making them have a bad time. It is this finding of a way to deal with those who do not treat one in the right way that can be called finding one’s voice. In this regard it is not necessarily about voice in the literal sense. A god example of how finding ones voice is not about finding the literal voice is the story by Flaa about her life in America as an Asian adoptee who constantly got bullied on the basis of her race. Flaa (Para 14) says she got her voice not necessarily literally but by being able to respond to people when they mocked her due to her Asian descent. To illustrate this, she talks about an incident where she was mocked by a group of college boys by producing sounds that mocked the Chinese language. She managed to show her middle finder and got them apologizing. She compared this to the many instances where she could respond to such racist remarks by dropping her head and laying low. But that particular day, she was able to get back at the bully. She says that although she was not necessarily proud about her showing the middle finger, she was happy because that incident was an indication had she had found her voice. However, finding a voice can also be about finding the voice literally. This can be seen in Osman’s story that talks about how she got her voice back, literally, after she had lost it. Osman (Para 1) talks about how she got her voice back after she had lost it after having a mental break down and being hospitalized with a diagnosis of psychosis. She talks about applying for a library membership and reading some books helped her not only regain her lost voice literally, but how it also helped her to recover from the psychosis. Denzel (Para 17) talks about how his maturity has helped him to respond to racist advances. He compares how

Organizational Commitment to Diversity in Non Profit Organizations Research Paper

Organizational Commitment to Diversity in Non Profit Organizations - Research Paper Example Since cancer doesn’t allow any kind of discrimination and has no boundaries, it is important for organization to ensure that it has appropriate mix of employees belonging to various ethnic groups and races so that they can serve every patient well. Every year, more than 1.4 million Americans are diagnosed with cancer and they belong to various culture, ethnic groups, and race and have even conceivable background of cancer. The basic belief of ACS is to promote diversity and inclusion as part of their mission to eradicate the cancer issue as a foremost health problem. ACS Mission Statement â€Å"The American Cancer Society is the nationwide, community-based, voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives, and diminishing suffering from cancer, through research, education, advocacy, and service.† (ACS, 2012) International Mission Statement â€Å"The American Cancer Society's international mission concentrates on capacity building in developing cancer societies and on collaboration with other cancer-related organizations throughout the world in carrying out shared strategic directions.† (ACS, 2012) ACS Commitment to Diversity At ACS, the management team strongly emphasizes the importance of diversity in the workforce as they have patients belonging to various backgrounds. According to Otike, Messah and Mwalekwa (2011).

Gender is not something one is, it is something one dose it is a Essay

Gender is not something one is, it is something one dose it is a sequence of acts, a doing rather then a being - Essay Example Butler (1986) states that the common thinking about how a female becomes a woman is governed by patriarchy and phallogocentric language â€Å"which precedes and determines the subject itself† (Butler, 1986, p. 36). In other words, Butler (1986) believes that the term â€Å"woman† is defined passively, not by the women themselves, but by the patriarchal culture. That said, de Beauvoir (1973) believes that oppression is not inevitable, but, rather, they persist because of cultural reasons. Butler (1990) further states that the concept of a universal patriarchy has come under fire, because patriarchy exists in â€Å"concrete cultural contexts† (Butler, 1990, p. 3). Butler (1990) also states that there is the possibility that women might have a bond through their oppression alone. Connell (1992) further states that gender, in and of itself, is a construction of power and hegemony, which means that the male identity is also influenced by culture and these outside forc es. Connell (1992) believes that masculine identities may be hegemonic or marginalized – some masculine identities are the former, others are the latter. Similarly, there is a difference between masculinity and femininity, and this, too, is contrasted with the terms â€Å"male† and â€Å"female.† Bartky (2003) states the one achieves femininity, whereas one is born female. The same with masculinity – men might achieve masculinity, and be born male, or, alternatively, as with many homosexual men, one may be born male but not achieve masculinity. As with the philosophies of de Beauvoir and Butler, Bartky (2003) states that the concept of masculinity and femininity is dictated by the power structure, which states what the contours are of masculinity and femininity (Bartky, 2003). This article will examine how patriarchy and society has defined both men and women throughout the modern era. Discussion Standards of Beauty As de Beauvoir (1973) states, the femin ine identity, and what it means to be a woman is defined by patriarchy and the male. In no area of a woman’s life is this more apparent than the standards of beauty, which are male-dominated. Women feel that they must conform to these male-dictated beauty standards, or they are somehow less than. The feminine ideal for beauty, therefore, is not only ever-changing, but is dictated by the power structure and patriarchy. Lorber (1993) states that the feminine ideal, at least during the early 1990s, which is when Lorber’s article was written, was slim-slim-hipped, small breasted and virtually emaciated. Women starved themselves for this ideal, and this ideal sold many magazines which promised women a way to become thinner, in order to fit this ideal. While this was the ideal in the early 1990s, and, more or less, continues to be today’s ideal, this was not always so – the feminine body ideal has changed over the years, according to society and culture. Calabr ese et al. (2011) state that the feminine ideal is epitomized by Playboy models, which is similar to the ideal stated by Lorber (1993), in that the women is to be slim-hipped and slender, overall. However, in this ideal, the woman must also have large breasts. Barbie dolls exemplify this ideal, and girls and women increasingly pressured to fit this ideal, to the extent that they require plastic surgery to do so (Calabrese et al.., 2011). Frederick et al. (2007) state that these feminine ideals, as pushed upon society by

Introduction to Quality Assurance Essay Example | Topics and Well Written Essays - 750 words

Introduction to Quality Assurance - Essay Example Improvements in the patient satisfaction by increasing quality of care, will in itself lead towards reduction of risk. The basic steps in the design of the risk management strategy for the hospital are as follows: Being a military hospital, the biggest risk it faces are times of war. This is an area where it should be prepared in. The hospital has a good history of being able to perform in war times. They are so confident on their abilities that a whole section has been dedicated on the website to this issue in fact. Other than this, the hospital mainly focuses on patient satisfaction and increasing the quality of services that they presently are offering to existing patients. This is particularly true for newly registered patients who need to be retained. The risk management process heavily relies on the total quality management department of the hospital. The major responsibility is on the head of the Command Risk Manager who needs to make sure that the risk management process is up to date and has not missed out on anything. He has to ensure that any new developments in the hospital are incorporated into this plan. This also includes that these practices should be in accordance with the Bureau of Medicine and Surgery (BUMED) and the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) rules and guidelines. Review and Evaluation of Plan When the planning stage has been developed, the time comes for the actual actions to be derived out of the planning. In this case the Naval Hospital hopes to make sure that losses will be able to be minimized and harm will also be prevented to the maximum extent. This is particularly important since the place exists for this very purpose only. This also means that the staff and the facility will be saved from any blame for any unforeseen accidents or mishaps. The benchmark that I am going to compare this Hospital to is the Naval Medical Center San Diego. The main reason for selecting this benchmark is that comparison between two same sort of things eliminates any discrepancies and confusion which might arise in the minds of readers. Now, being a bigger and more prosperous facility, the San Diego Naval Medical Center immediately has an advantage. It will get more customers than the Naval Hospital Guam. The biggest difference is that the Naval Medical Center San Diego is a "Center" while the Naval Hospital Guam is just a "Hospital". This means that the Naval Medical Center San Diego has to provide much more to its patients in forms of services and quality than the Guam Facility. So, all planning done by the Naval Medical Center San Diego is more thorough and covers a much more wide area to lower costs and provide a better overall understanding by the staff by reducing their confusion of the management practices. This makes the risk manageme nt program of Naval Medical Center San Diego a bit blurred compared to the Guam Hospital, as they can fine tune it without much changes and confusion, giving it the needed edge. There are not many things wrong with it actually. This plan is developed keeping many things in mind by the administration like lowering costs and so on.

Educator Role Strategic Plan Presentation Research Paper

Educator Role Strategic Plan Presentation - Research Paper Example There are two basic reasons to this, firstly the healthcare has gone phenomenal advancements and secondly the public awareness on the issue of health and safety had never been so vivid like we experience it today. However, the basics criterion to meet these challenges has not changed much and that it requires your whole hearted commitment to the profession even today. Being an educator, you are required to enable and enrich others through your contribution and personal example and develop and prepare them for the challenges of the nursing profession. To be a good educator you first need to be good learner and should have the capacity to correct and develop skills of the trade instantly and for this you have to have some personal qualities. Therefore, to assess the personal capabilities and tendencies it is important to have a self criticism before choosing yourself as a right candidate for the nursing educator role. This self assessment and knowledge of personal guts and shortcomings is vitally important for a strategic plan of next few years so that you can realistically set your future goals. I had started my professional career some fifteen years ago as an associate nurse in a local hospital. Throughout my professional career I found myself quite comfortable with the demands and routines of the trade. Perhaps all these things have now become a second nature for me and I enjoy my job as nursing supervisor. This long experience in the field of nursing has give birth to many personal qualities and have additionally polished my thrust for knowledge. As a nurse you have to adopt several roles during your career and none of those role can be performed without profound knowledge and expertise of the field. My career has grown me into a nurse of solid clinical background and I have been performing my duties to the highest satisfaction of my seniors. So I find it quite soothing that my love for knowledge and professional competence can support me in my future goal ac hievements. But this comes with responsibilities and I found myself compelled to enhance my educational competence. Another important skill that my profession has inculcated into my personality is to learn and share in team environments. This has brought me multifaceted benefits as a learner as well as a trainer. I have been working many a times in such capacities where I had to train my junior colleagues and have found myself quite comfortable with the job. Teaching has been an enjoyable experience for me. It had not only imparted knowledge to me but has also given me confidence to adopt it as my professional career. The communication skills are indispensible for any such role in my future and though there it had been quite easy going for me while communicating and sharing knowledge with others I have identified few gray areas as well where I have to address certain issues with my communications skills. Additionally, my inability to avoid debates in certain environments may cause s erious problem in the attainment of my strategic targets. It is always advisable to get rid of unhealthy discussions; discussion just for the sake of discussion. Secondly, more often than not I find it very difficult to resist sleep. This obviously, I am talking about the extra bit of laziness while having completed a healthy sleep

Complete standartisation of offerings and marketing interactions in Essay

Complete standartisation of offerings and marketing interactions in International Marketing strategy is always the main goal to - Essay Example The economic reforms adopted by the governments in different economies across the world led to the inflow of investments by the companies in the foreign countries which opened up the global markets for the companies of different sizes across the world. The transformation in the business environment led to the modification in the international strategies adopted by the companies. Thus the marketing environment and the culture of the companies underwent rapid changes over the period of time. The developments in the market environment and the strategies adopted by the organizations have come up in order to respond to the changes in the consumer behaviour and demands of the customers in the economy. The advancement in communication technologies and other online applications as a result of strategic implementations in the global markets have changed the outlook of the customers of the companies. The customers have become more aware of the information on the products and the services offer ed in the global arena. The level of awareness of the customers has increased and they have started to weigh the different options for the products and services offered by the companies in the international markets. The customers have learnt to define their needs in a far better manner and seek solution to satisfy their wants on a consistent basis (Andrus, 1990, p.430). Apart from this, there have an increase in the competition among the business houses for offering the products and services in the market. In order to gain competitive advantage, the companies started to focus on their strategies to avoid duplication of information on the products and services offered by the company. This led to the standardization of the offerings and marketing interactions as an important trend in the international marketing strategies of the companies. International Marketing strategy The standardization of product offerings and marketing interactions is extremely important for the multinational c ompanies in order to increase the acceptability of the business in the eyes of their customers. As the approach of standardization helps the companies to achieve success in the business operations, the multinational companies include this approach in the international marketing strategies designed by the multinational organizations. The companies that have wide spread operations in various markets across international boundaries considers the changing trends of consumer behaviour in order to design international marketing strategies that are important for achieving successful and sustainable business operations. The experience and learning gathered by the companies in the local markets are applied to the several foreign markets where the company has expanded its operations. The companies ensure that there is no duplication of the information available to the customer on the product and service offerings of the company in different international markets. The international marketing s trategy also takes into account the activities of promotion and marketing interaction done by the executive in several foreign markets. The sequence of penetration and expansion of the business in the foreign markets are important part of the international marketing strategy (Cavusgil, 1994, p.20). The multinational companies that operate in the different foreign market are faced with situations of varying market demands and consumer behaviour

Example of Business Report Essay Example for Free

Example of Business Report Essay Executive Summary The purpose of this report was to investigate a student club at a private university in Jakarta, which is called BNEC (Bina Nusantara English Club) at BINUS University. BNEC is a non-profit English organization for undergraduate students of any major studying at BINUS University. Its main purpose is to develop its members’ English skills by providing TOEFL, Debate, Scrabble, Spelling Bee, Public Speaking, and Performing classes. BNEC has actively participated in various national and international competitions. The strengths of this organization can be seen from many national and international achievements that this unit has achieved. The main reason for its success was due to its strong leadership sustainability, which allowed the changing leaders and committees of the unit always manage to accomplish the set targets and goals. Moreover, its tight selection  process for the new members has resulted in highly proficient English participants, readily supporting the arranged activities. Lastly, the high-quality training programs available have contributed to a rigorous and intensive practice of using English for public performances. However, the unit has some areas for improvement. For example, the communication styles between supervisors and subordinates were sometimes problematic, as all participants underwent the learning process of teamwork communication. The unit has also developed a certain degree of arrogance and pride, which even widened the gap between the unit with other lower proficient students studying in the university, and thus developing and strengthening its exclusivity. After taking both strengths and weaknesses into consideration, it is recommended that BNEC should begin to develop more social programs, carefully designed to help their fellow students outside their organization in the university, or even to other marginal members of the society living near the university, to improve their English proficiency and establish BINUS University and its surrounding areas as the English as a Second Language (ESL) area. 1. Introduction 1.1 Purpose The purpose of this report was to investigate a student club at BINUS University, namely BNEC (Bina Nusantara English Club), and recommend a suitable solution to its problems and some suggestions for its future development. 1.2 Scope When investigating BNEC, it was important to consider its current conditions in terms of its organizational structure, management/leadership style, materials development, marketing/promotion, programs and training. 1.3 Method The information used in this report was collected by having some interviews with personnel in BNEC, including the chairman, secretary, treasurer, promotion team, program coordinators, and some members. 1.4 Limitations PICs and members were sometimes difficult to meet Important information is difficult to collect †¦. 1.5 Assumptions It has been assumed that BNEC has not proved effective and efficient in running the organization. As the members actively participate in its programs and activities, it has been assumed that the implementation of its training programs shows little contribution to improving their proficiency levels. As most BNEC programs have generated many awards and prizes, it is assumed that there are still programs that do not result in significant achievements. 1.6 Background BNEC was established in 1992. It is the only English-based student unit at BINUS University. Its main purpose is to develop the member’s English skill by providing TOEFL, Debates, Scrabble, Spelling Bee, Public Speaking, and Performing classes. BNEC also actively participates in a variety of national and international competitions. It has achieved many achievements. Besides these, it is also widely acknowledged for its event organizing. BNEC was awarded The Best Student Organization in 2010, 2011, and 2012 by BINUS University. 2. Findings 2.1 Strengths Strong communication channels among members A variety of programs offered Active and supporting team members †¦. 2.2 Weaknesses Less involved in CSR (Corporate Social Responsibility) programs Focused only on one main headquarters, no branches Limited resources for programs development †¦. 3. Discussions 3.1 (Organization Structure) – this is just an example – Generally, BNEC consists of three big departments, which are ‘Information and Development’, ‘Product and Achievement’, and ‘Marketing and Communication.’ Each department has its own unit. In total, BNEC has 12 units, which are managed by the Board of Management. In the author’s perspectives, the way the organization is structured brings out some problems. For example, †¦.. 3.2 (Management and Leadership Style) All Board Management at BNEC are carefully selected, and each of them plays an important role in running the organization. †¦. 3.3 (Resource Development) †¦. 3.4 (Marketing and Promotion) †¦. 3.5 (Programs and Training) †¦ 4. Conclusion After investigating BNEC, it was found that †¦. It is important to consider the long term benefits to the organization when considering which programs or events were best conducted. †¦. The management style had to be easily adaptable for new opportunities such as †¦. †¦. 5. Recommendations and Implementation The findings and conclusion in this report support the following recommendations: The board of management needs to adapt to †¦ Programs need to be developed based on †¦.. Members must have email or online access on their electronic gadgets to enable them to be in contact with the organization at all times All marketing and promotion team should negotiate price and ongoing service agreements with external parties To reduce the organization long term expenses: The organization could investigate the viability of †¦. †¦. Training programs available for members should have the maximum duration of 1.5 months (6 weeks) 6. References http://mybnec.org/view/about.php

Individual Reflection Report On A Business Plan

Individual Reflection Report On A Business Plan The following reflective journal has been produced by me as a work that redirects my business plan that has been prepared by my group of five members. The main reason for writing the journal is to reflect my work and my role as a team member while undertaking the research for business plan. Other purpose of preparing the report is to present my personal records and include my thoughts and experiences that I have achieved during the project work. The MBA administration of the university instructed me to write an individual reflective journal on business plan that must be critical and analytical. I have ensured it is written to reflect on my work which will also enable the examiners to understand my achievements as an individual and as a member of a team. It will also provide help for supervisors to appreciate my role as a person who can confidently research, gather information, critically analyse, report and present. I have tried my best to be as specific as possible to make this refl ective report as a persuasive essay arguing on behalf of myself. This journal also includes information of research sources, my use of ideas and critical thinking to develop my awareness of the context in which I work. Along with the above mentioned areas, I have described my role as a tackler of a situation, as an important member of a team and as a person who approached any issues and challenges to reflection sheet with confidence and enthusiasm. Also included in this journal are understanding of relevant theories, problem solving, synthesis, strategic analysis, and explaining how I built upon and applied knowledge from taught modules. It has been ensured by me that wok structure must follow section headings and recognise marking scheme. Language is deliberately kept concise and the work is presented taking into account the school guidelines. Problem solving The MBA administration has allocated in a team of five students (including me). The task given to us to work on was a business plan concerning launching a business in Wales. The team members for this task were Ram Lakshmankumar Konda, Soto Santiago, James Joji and Yuvraj Singh. The business we chose to launch in Cardiff was Spectrum International Travel Agency (SITA) which offers services in corporate and commercial traveling. SITA is a partnership firm comprised of five partners with equal shares with a start-up capital of  £400,000. We planned to launch the business in the month of April, 2011 with a star-up capital of 400000 pounds jointly invested by partners who have equal shares and equal voting rights. The assignment required us to make a plan consisting of data regarding marketing, human resource and financial aspects of the contemporary management studies. In this journal I reflected upon my individual experiences as well as an influential member of a team explaining events such as planning, gathering data, analysing, reporting and presenting what I saw, I heard my hypotheses and my conclusions. I also evaluated the effectiveness and efficiency of what was observed. I was selected to be within a team of five members that have already been mentioned above. Although I specifically asked the supervisor to form a team with my friends but the teams were allocated randomly by the management. I was lucky that one of my close friends was on my team. The remaining team members have already had good contacts with me as they were my colleagues and classmates. My initial objections faded away once I started working with my friendly natured team members. All of us were motivated, determined and enthusiastic of completing the business plan. We met for an initial meeting and decided on the type of a business. I was quite influential as for my managerial background and practical experience in marketing and financial pathway. My team members recognised this and realised my natural leadership qualities. It was not difficult for us to select the business type. After careful consideration and brainstorming ideas with members, we managed to come up with a brilliant plan. Luck was on our side as our team members had different study backgrounds and I was naturally multi-skilled. It proved easy for us to divide the tasks according to our strengths. Once tasks were assigned and potential barriers to search identified, we consulted on how to maximize our strengths to reduce our weaknesses, and how to exploit the possible opportunities and remove threats. After that we constantly held meetings to discuss our progress and consult each other to improve our work. We continuously stayed in touch with each other via audio video conferencing and of course mobile phones. Being students from different cultures caused some tensions and some problems such as little understanding of each others ideas, lack of knowledge of some business management areas and conflict in decision making process. I again proved prominent and persuasive and managed to resolve all the issues harmoniously. Disagreements among team members were resolved and we worked together pleasantly. As a contemporary business management student, I had an idea due to my studies that the team capability is superior to the collective abilities of the individuals within it. I learned that working in a friendly environment make the job easier for team. Combined strengths can be utilized if team members work jointly in committed and motivated stance. Apart from problems mentioned above, my team faced some problems such as lack of knowledge in some areas, lack of experience in conducting research, lack of ability to analyse critically, and critical of each other work. We managed to resolve these i ssues professionally. As a team member my learning experience grew as I learned that team becomes a success when members work jointly to create a synergy. When team members know how to be more effective together, synergy happens and greater organizational success is achieved. The lessons that I have learnt being in a team are very crucial and I understood its significance. People bring their unique skills, knowledge and experience which when used in combination with skills and knowledge of other team members, helps in creating a synergy that positively effects the operations and functions of the team. This happened in my situation. Every member was motivated and worked with passion and determination. Increasing the strength of each team member produced greater team success and results. I understood that that collective strengths of team could tackle any problem we face. Knowledge and Understanding By actually participating in a joint research project, I understood the importance of team theory in practice. It provided me confidence to relate the theoretical study with my research. I acknowledged my roles and responsibilities by working effectively working in a team. My communication and coordination skills improved considerably. During the work, I have appreciated the idea of working together to achieve the common goal. I have learned that effective team working is the key to success when there are limited time and resources. Different point of views can be brought forward which could help in effective decision making. I found the energy of group participation made me feel more energetic about contributing something. The thing that helped me understand the approach of my team members is the constant contact and consultation with them. It also assisted me to learn and understand their ideas and experiences. Working with team on a business plan has helped me equip myself with cr itical and analytical skills to make an official report. I felt more skilled in searching various data sources and in using variety of research tools techniques and methods to conduct a research. The proposed business plan concentrated on marketing strategies of the company before during and after launch of its business. It focused upon the areas of market penetration, market segmentation and marketing growth. It also included finding out market trend and demand of the consumers. I forecast market share and business revenues using assumptions and financial projections. The companys approach was to recognise the importance of consumer service, facilities, ambience, and projection technology and operational benefits. I managed to educate myself practically with the knowledge of applying wide range of marketing models and techniques in business plan. It helped me to formulate strategic aim and objectives of the start up company. The reason of conducting the research was to identify and establish potential market and also to collect valid and reliable data. I understood the importance of critically analysing market information and data related to potential customers before entering the market. I studied to carry out market analysis; learned about market size and forecast; its share, trends and behaviour. I also assessed competitors and their strategies, targeted market segments, analysed our business core competencies and critical success factors; marketing and costing strategies. This business plan also assisted me in projecting financial position and reports along with knowledge of staffing and resourcing for business. Synthesis Despite dividing the tasks according to our strengths, we still faced issues. Although all problems were resolved properly but I would still like to change my future approach a little. I would definitely focus on time management and issues regarding motivation and interest. The areas I need improvements are my skills of critical thinking and analysing and assessing the market. I would also try to encourage positive criticism so that team members could improve their work. Experience gained from this project will definitely help to improve the above mentioned areas in the future. There are some factors that developed my understanding and improved knowledge. I learnt to conduct the research practically which were taught theoretically in workshops and lectures during my study in the university. Meetings provided facilitation in problem solving and strategic planning. These also helped me in decision making and working in a team. Analysis and Evaluation It was expected from a student studying master in business administration to think and analyse critically. The lectures I have taken during my studies and the courses that I have attended provided a great help in applying marketing tools and techniques to my research. These also assisted me applying theories into practical scenario. I gained bot theoretical and practical knowledge. I applied my studied knowledge of the books; journals and coursework make and plan a strategy for the company. Models e.g. Porters generic strategies, McKenzie 7s model, Porters five forces model and Ansoffs growth model, have been applied successfully. The knowledge from the lectures helped me search various data sources. The effective use of theoretical knowledge in practical scenario proved helpful in understanding the business plan. I applied a number of marketing theories to advance my knowledge of the business plan. I steadily built my practical experience upon the theoretical knowledge. Theory taugh t me the ways to carry out research; I practically collected data on filed. Theory taught me various ways of measuring the data; I practically applied some in financial projection; Theory explained how to apply different models; I managed to use these theories according to my situation and constructed a whole report. After successfully completing the project, I learned to better argue, use facts and examples and debate efficiently on management issues. The business plan helped me to be good, confident, cooperative and effective team member. My researching skills increased considerably. Now I can use different research which can help me in future research process. It taught me to create a conclusive argument, present the paper clearer and arguments more apparent. Collecting data, analysing it, writing it in a proper format and presenting it to the board has given me a sense of achievement and pride. In comparison to my own skills before working on this project I did make a lot of progress. I personally feel that business plan is more feasible as it helped me understand not just to applying critical thinking and analysing the information but to use the theory into practice. It helps the students getting management experience and applying what they have learnt in their lectures and workshops.

The Post-War Era Essay -- After WWII, 1945-1950

The Second World War concluded and the United States became the single most powerful nation in the western world. American history explains the participation of America in the international arena effectively, but when it comes to the domestic arena much is excluded. History has deprived new generations from being able to acknowledge the essential changes that took place within the United States during the Post-war era. The most common struggle during this time period was the return of American veterans to home ground. Millions of men returned to their hometowns and newly developed cities to settle down and create a family. However, these men were soldiers and pre-war students, but did not have a set place within the Post-war era society, therefore creating distress and struggle. Additionally, within the country’s boundaries over a hundred thousand Japanese-Americans were liberated from internment camps and prisons. These Japanese immigrants and descendants had been imprisoned for two years or more because of an anti-Japanese movement that took place during World War II. Generally, after the war the American society as a whole was in a shift to integrate itself to new demands, and this, as any other period of change is â€Å"interesting† (Goulden 6). In this time period of the post-war era we are able to see how identity for a new era is created. According to the Oxford American Dictionary, identity is the fact of who or what a person or something is. Thus, the identity of a person is relative to what a person finds himself able to do or be within the environment that surrounds him. Identity, which makes up a character of society, is the initial foundation to society as a whole. Since the individual is the principal foundation of so... ...that took place within the era, we would not have had a presidential election in which a women and an African-American battled for control of the American nation and its colossal power. Plainly, America rose like a phoenix from the ashes thanks to the post-war years. Works Cited Goulden, Joseph C. The Best Years 1945-1950. New York, NY: McCellan and Stewart Ld., 1976. Henthorn, Cynthia Lee. From Submarines to Suburbs: Selling a Better America, 1939- 1959. Ohio: Ohio University Press, 2006. Print. Hayden, Dolores. Redesigning the American Dream: The Future of Housing, Work, and Family life. New York, NY: W.W. Norton & Company, 1984. Kaplan, Fred. 1959. Hoboken, NJ: Wiley, 2009. Print. Okada, John. No-No Boy. New York: University of Washington, 1978. Yates, John. Revolutionary Road. New York, NY: Vintage Contemporaries, 1989.

Philip Larkins Faith Healing Essay -- Philip Larkin Faith Healing Poe

How typical in terms of subject, theme, structure and versification is Faith Healing by Larkin? Philip Larkin's Faith Healing In 1964, Philip Larkin published his third book of poetry, entitled 'The Whitsun Weddings'. One of the many critically acclaimed poems was 'Faith Healing'. In this essay, I intend to explore how typical this poem is in terms of subject, theme, structure and versification. In Faith Healing, women flock to an American Faith Healer for a blessing. The persona of the poem is written from an outsider's point of view, looking in at this sight. Faith Healing is divided into three stanzas, each of ten lines. Iambic pentameter is used to give 5 major stresses to each of the 10 lines. The three stanzas actually contribute to the action of the poem. In the first stanza, the women go forward to the Faith Healer; in the second, they leave and 'Sheepishly stray'. Finally, the poem concludes with the third stanza where Larkin analyses the situation. This versification is indeed quite typical throughout The Whitsun Weddings. 'Here' is another poem from this collection, and Larkin again writes in iambic pentameter. He uses the traditional versification to describe a journey from an industrial city to a place where much more satisfaction can be gained. This journey was also mapped by the structure of the poem. Larkin wrote 4 stanzas and each one marked a progression in the journey. This is similar to Faith Healing where each stanza moves the story onto the next event or occurrence. It is a similar case for 'Mr Bleaney' where every line is written in iambic pentameter, with only one exception for the first line. This poem also tells a story with the first four verses being descriptive befo... ...t we really desire whereas Faith Healing suggests that if these women had realised their loneliness earlier in life, they could have loved and been loved in return. This is only a slight difference; but is worth considering when asking the question of the typicality of Faith Healing. Overall, I feel that the similarities outweigh the differences and it can be concluded that Faith Healing is infact quite similar to a selection of the other poems in Whitsun Weddings. There are some differences and Faith Healing is unique in some respects, such as Larkin not experiencing this event personally. However, overall Faith Healing is a typical Larkin poem, with deprivation and loneliness as themes, iambic pentameter and enjambment as language features and with initially descriptive stanza's before moving on to conclude with a reflective and thoughtful panorama.

The poem Two Scavengers in a Truck, Two Beautiful People in a Mercedes

The poem Two Scavengers in a Truck, Two Beautiful People in a Mercedes is a descriptive poem by Lawrence Ferlinghetti. Night of the Scorpion & Two Scavengers in a Truck, Two Beautiful People in a Mercedes The poem Two Scavengers in a Truck, Two Beautiful People in a Mercedes is a descriptive poem where the poet (Lawrence Ferlinghetti) observes two garbage men in San Francisco and two well-paid people in a Mercedes. The poet's observation is really about the way the garbage men look at the well-paid people and the way the rich people look at the garbage men when waiting at the traffic lights. This poem is about two garbage men and two posh office people in the Mercedes who stop at the same traffic light at the same time on the same day. The main reason I enjoyed this poem was because of the description of each person in the poem. One description I really liked was the description of the two people in the Mercedes, '' The man in the hip three-piece linen suit with shoulder-length blond hair & sunglasses The young blond women so casually coifed with a short skirt...

History of Indian Pharma Industry

CHAPTER: 1 INTRODUCTION History of Indian Pharma Industry The  Pharmaceutical industry  in  India  is the world's third-largest in terms of volume and stands 14th in terms of value. According to Department of Pharmaceuticals,  Ministry of Chemicals and Fertilizers, the total turnover of India's pharmaceuticals industry between 2008 and September 2009 was  US$21. 04 billion. While the domestic market was worth US$ 12. 26 billion. Sale of all types of medicines in the country is expected to reach around  US$19. 22 billion by 2012. Exports of pharmaceuticals products from India increased from US$6. 3 billion in 2006-07 to US$8. 7 billion in 2008-09 a combined annual growth rate of 21. 25%. According to  PricewaterhouseCoopers  (PWC) in 2010, India joined among the league of top 10 global pharmaceuticals markets in terms of sales by 2020 with value reaching US$50 billion. Some of the major pharmaceutical firms including  Sun Pharmaceutical,  Cadila Healthcare  and   Piramal Healthcare. The  government  started to encourage the growth of drug manufacturing by Indian companies in the early 1960s, and with the Patents Act in 1970. However, economic liberalization in 90s by the former Prime Minister  P.V. Narasimha Rao  and the then  Finance  Minister,  Dr. Man Mohan Singh  enabled the industry to become what it is today. This patent act removed composition  patents  from food and drugs, and though it kept process patents, these were shortened to a period of five to seven years. The lack of patent protection made the Indian market undesirable to the multinational companies that had dominated the market, and while they streamed out. Indian companies carved a niche in both the Indian and world markets with their expertise in reverse-engineering new processes for manufacturing drugs at low costs.Although some of the larger companies have taken baby steps towards drug innovation, the industry as a whole has been following this b usiness model until the present. India's  biopharmaceutical  industry clocked a 17 percent growth with revenues of Rs. 137 billion ($3 billion) in the 2009-10 financial year over the previous fiscal. Bio-Pharma was the biggest contributor generating 60 percent of the industry's growth at Rs. 8, 829 crore, followed by bio-services at Rs. 2, 639 crore and bio-Agri at Rs. 1, 936 crore. The number of purely Indian Pharma companies is fairly low.Indian Pharma industry is mainly operated as well as controlled by dominant foreign companies having subsidiaries in India due to availability of cheap labor in India at lowest cost. In 2002, over 20,000 registered drug manufacturers in India sold $9 billion worth of formulations and bulk drugs. 85% of these formulations were sold in India while over 60% of the bulk drugs were exported, mostly to the United States and Russia. Most of the players in the market are small-to-medium enterprises; 250 of the largest companies control 70% of the Ind ian market.Thanks to the 1970 Patent Act, multinationals represent only 35% of the market, down from 70% thirty years ago. Most Pharma companies operating in India, even the multinationals, employ Indians almost exclusively from the lowest ranks to high level management. Mirroring the social structure, firms are very hierarchical. Homegrown pharmaceuticals, like many other businesses in India, are often a mix of public and private enterprise. Although many of these companies are publicly owned, leadership passes from father to son and the founding family holds a majority share.In terms of the global market, India currently holds a modest 1-2% share, but it has been growing at approximately 10% per year. India gained its foothold on the global scene with its innovatively engineered generic drugs and active pharmaceutical ingredients (API), and it is now seeking to become a major player in outsourced clinical research as well as contract manufacturing and research. There are 74 U. S. FDA-approved manufacturing facilities in India, more than in any other country outside the U. S, and in 005, almost 20% of all Abbreviated New Drug Applications (ANDA) to the FDA are expected to be filed by Indian companies. Growths in other fields notwithstanding, generics are still a large part of the picture. London research company Global Insight estimates that India’s share of the global generics market will have risen from 4% to 33%. The Indian pharmaceutical industry has become the third largest producer in the world and is poised to grow into an industry of $ 20 billion in 2015 from the current turnover of $ 12 billion. The Indian pharmaceutical industry is a success story. 00 000 people are employed in this sector, in some 12 000 firms. 2 900 of them are large scale units, following a recent article by Pradeep Aggrawal and P. Saibaba in the renowned Economic and Political Weekly of Mumbai (29 September 2001). In the pre- and post-production sector, a further 2. 5 mil lion jobs are thought to be involved. Compared to the general price index, drug prices have risen much less in the last 15 years and remain far below average. â€Å"Worldwide, India is a  country of very low drug prices while producing high quality medicines†, Nihchal H.Israni, president of the Indian Drug Manufacturers’ Association (IDMA), states proudly. Self-sufficiency with regard to pharmaceutics exceeds 90 percent – in spite of the policy of a more open economy pursued by India since 1991. The secret of this success is the Indian Patents Act 1970. India had entered independence with the patent system of the British  colonial masters, enacted in 1911. This secured the Indian market for the British industry. Prior to 1970, multinational  companies dominated the Indian market with a share of 85%, pharmaceutics were largely imported whereas local production remained minimal.Section 83 of the Patents Act 1970 states â€Å"that patents are granted to enco urage inventions and to secure that the inventions are worked in India on a  commercial scale and to the fullest extent and not to enable patentees to enjoy a monopoly for the importation†. At the turn of the century, the share of multinationals had declined to a share of 40 percent of India’s market, including a substantial share of local processing by multinationals. 45 of the larger scale production units belong to multinational  companies. The â€Å"architect† of the patent law of 1970, S.Vedaraman, then director of the Indian Patent Office, summarizes the spirit of the law as follows: â€Å"We are not against patents. And we are prepared to pay decent license fees. But we in India cannot afford monopolies. † Since then, India has done without product patents for pharmaceutics, with the exception of production processes that may be patented for seven years. In addition, the law allowed for  compulsory licenses granted by the state, in the case of a patent holder not granting voluntary licenses on fair  conditions. India profited from a large section of well-qualified experts who made good use of the new opportunities.These moves did not find much favor with the multinational Pharma-industry. It should not be forgotten, though, that in many industrial  countries, the protection of inventions through patents was only developed in the last 30 years. The Swiss pharmaceutical industry in particular fought the enactment of a patent law at the end of the 19th century, in order to be able to imitate foreign drugs, such as Aspirin. In the German Reichstag (Parliament) Switzerland was  considered a â€Å"state of robber barons†, in France a â€Å"country of counterfeiters†.Product patents for medical drugs have only been known in Switzerland since 1978. It is very clear whose interest they serve. Technology exporters profit from patent protection, which shields them from low-cost  competition. Technology importe rs – in other words, most of the developing  countries – want access to technical innovations as freely and cheaply as possible, i. e. no patent protection which creates monopolistic barriers. Indeed it was in this way that the economic development of Japan, Korea and Taiwan was able to thrive, due to the beneficial absence of patents.The Cipla philosophy has for decades been to promote the principle of relying on one’s own strength. â€Å"For India, this means striving for a high degree of self-sufficiency in vital areas of health and nutrition, and for our business practice, it means aiming for the fulfillment of the needs of the Indian population, the use of indigenous raw materials and of local personnel†, says Cipla managing director Y. K. Hamied. This philosophy,  combined with technical expertise, must have been the reason that the Indian  Council for Medical Research suggested to Cipla in 1990 that the AIDS drug Zidovudine be produced locall y.Due to the state investing its limited means in prevention, the market remained small. In India, approximately US$ 2 million is turned over yearly for AIDS drugs. Of this, Cipla has a share of about 80 percent. This is only a small percentage of Cipla’s total turnover of more than US$ 210 million. Indian Pharma industry is very interested in the export of its pharmaceutics. Developing  countries are an important market for Indian manufacturers because they produce high quality products at very  competitive prices. But free trade is hampered by national and international patent rules.For a patent does not only constitute the sole right to produce a product but also to import it. Despite these barriers, India’s drug exports exceeded in the year 2000 for the first time US$ 1. 5 billion. The success story of the pharmaceutical sector is part of a wider but less known â€Å"economic miracle†: India achieved average rates of economic growth for the last 20 years of six percent annually. Major Pharmaceutical Companies in India: In the list of top pharmaceutical companies in India it is not the Indian companies but also the MNCs that are becoming the part of the race.Indian pharmaceutical market in 2008 was $7,743m and if compared to year 2007 it was 4% more than that. It is expected that Indian pharmaceutical market will grow more than the global pharmaceutical market and will become $15,490 million in 2014. Today Indian pharmaceutical industry is the second most fastest growing industry displaying the revenue of Rs 25,196. 48 crore and growth of 27. 32 percent. Top pharmaceutical companies in India are also acquiring the small companies worldwide to further expand the market. Injections, tablets, capsule; syrups are the products of Pharma companies in India.Looking back into history reveals that it was in 1930 when the first pharmaceutical company in India came into existence in Kolkata. It is called the â€Å"Bengal Chemicals and Pharmac eutical Works†. This Indian company is still there and today it is the part of five drug manufacturing companies that are owned by the government. Till the period of 60 years the pharmaceutical industry in India was overshadowed by the foreign drug manufacturing companies but with the Patent Act in 1970, the whole scenario of pharmaceutical companies in India had changed since then.With this the Indian market was more open to Indian pharmaceutical companies than the MNCs. So with this pharmaceutical companies in India started to grow in number At present there is a cut throat competition among top pharmaceutical companies in India with the native as well as MNCs. But there are certain issues that are concerning the growth of Pharma companies in India. These are: ? Mandatory licensing and failure of new pattern system. ? Regular power cuts and inadequate infrastructure. ? Restricted funding. ? Regulatory hindrances that lead to the delays in the launch of new drug or Pharma pro duct. Too many small as well as big pharmaceutical companies and excessive competition. Top 10 Pharmaceutical Companies in India |Rank |Company Name |Turnover Amount |Remarks | |1. |Ranbaxy |4198. 96 | | |2. |Dr. Reddy Lab. |4162. 25 | | |3. |Cipla |3763. 72 | | |4. |Sun Pharma |2463. 9 | | |5. |Lupin labs |2215. 52 | | |6. |Aurobindo Pharma |2080. 19 | | |7. |Galxo Smithkline |1773. 41 | | |8. |Cadila Healthcare |1613. 00 | | |9. |Aventis |983. 80 | | |10. IPCA Laboratories |980. 84 | | COMPANY PROFILE Medley is a global pharmaceutical company operating since 1969 from Mumbai, India. Since launch, the company consolidated its position with a strong marketing infrastructure. In the year 1976, a formulation plant with modern facility was set up at Aurangabad followed by a couple of units placed at Daman and Jammu. Medley has state of the art facilities maintaining high quality standards at every further stage in manufacturing process with strict adherence to the Good Manufacturing Pr actices.Medley Pharmaceuticals Limited is a multidivisional and multi location organization with strong presence in Pharmaceutical formulations. The specialties include Hematinics, Anti ulcerants, Anti bacterial, Pain management, Gynecology & cardiovascular drugs. We specialize in Iron preparations, our mega brand being R. B. Tone Syrup. We also have many 1st time in India brands to our credit like Dompan (Domperidone & Pantoprazole), O2 (Ornidazole & Ofloxacin), Tazocef (Tazobactum & ceftriaxone) & Osmium K2 (1st brand of Vitamin K27 combination in India)Medley ranks amongst the top 40 pharmaceutical companies in India as per ORG IMS. Medley believes that quality is a continuous process and not an isolated stage in the process. They have an extensive distribution network across the country with 5 Depots, 17 C/Fs & over 1500 Stockiest which caters to the retailers. Research & Development The inbuilt quality of products is assured through scientific way of product development at R&D scale, transfer of technology from lab scale to mass production, analytical method development, stability studies and process validation.Our current thrust is towards development of innovative dosage forms in the areas of tablets, syrups, aerosols & other types of herbal formulations found in India. We believe that only through integrity one can provide the best medicine to patients whose well being is valued the most as per the company perspective. Medley has established state of the art R&D centers at Daman and Mumbai equipped with the latest ultra modern instruments. These R&D centers have highly experienced team of scientists having post graduate & doctorate degrees in the field of pharmacy & chemistry.The R&D centre established at Daman has received approval of Department of Science and Technology, Govt. of India in 2006. WORLDWIDE OPERATIONS [pic] Medley has set its eyes on becoming a truly global pharmaceutical company over the next decade. Medley's products reach 26 countrie s with significant presence in Asia, Africa, Middle East, Russia and CIS Medley intend to enhance its International presence based on its policy of â€Å"Integrity in Medicines† and quality of products. Medley already has setup the office in UK and tied up with partner in USA and SA.Medley is aggressively working on finalizing its business tie-ups in Brazil. Medley has dynamic team and representative office in Vietnam, Myanmar, Cambodia, Sri Lanka, Kenya, Russia and Kazakhstan. The dynamic field force promotes its specialty formulations. Around 514 formulations are registered in 26 countries. Today International business contributes 12% of Medley sales, but expected to grow substantially in the next three years. We have three manufacturing facilities, two at Daman and one at Jammu which strictly follows WHO GMP guidelines.All our manufacturing facilities are the state of art manufacturing units for oral and liquid section. The Daman Facility is MHRA-UK approved. One of our fa cilities at DAMAN is certified for Good Manufacturing Practices (GMP) Conforming to INTERNATIONAL STANDARDS by Competent Regulatory Authorities in Uganda, Sudan, Tanzania, Malawi, Ethiopia, and Yemen. Medley is now preparing for the South Africa. This initiative of Medley would help strive for the growth and to serve the world community. COLLABORATION Collaboration is Key to Our Success:-Collaboration, cooperation and partnership are the keys to our success. We are committed to working with our corporate partners to  offer our research, development, regulatory, manufacturing, marketing and sales expertise. Identifying good partners and managing long-term relationships is part of our company philosophy. Contract Manufacturing Why Medley for Contract Manufacturing? Medley understands the outsourcing requirements of its customers and transforms their needs into solutions. The pharmaceutical industry today is acing challenging business environment due to escalating R and manufacturing costs as well as delays in bringing new drugs to market. Other key factors impacting the industry include: †¢ Ever increasing demands to deliver lower cost of goods & improve customer supply performance †¢ Greater product complexity †¢ Ongoing regulatory compliance demands By using our contract manufacturing services you can access Medley's comprehensive technology portfolio for pharmaceuticals and the competence we have built up over decades.Knowledge, modern technology and creativity combined with clear and well-defined communication procedures between our teams of experts and customers & above all consistency, world class quality & delivery ahead of time are the key factors for achieving optimum solutions that will surely exceed your expectations. Complete confidentiality and protection of client intellectual property is the heart of the Medley culture. In-Licensing We look at partnering and collaborating as an important strategic approach that will complement our growth in India and international markets.We believe in brand building & are leaders in various therapeutic segments with 3 brands featuring in top 300 (IMS-Health). Our extensive distribution network with more than 1500 stockist’s, 6 depots & 16 C&F’s backed by 40 years of marketing experience & strong field force of over 1500 representatives enables us to achieve the leadership position in various therapeutic segments. We use collective experiences and resources that have been proven to work at the highest levels of efficiency to help brands better succeed.Our core areas of marketing expertise include the gastroenterology, cardiovascular, dialectology, gynecology & Orthopedic therapy areas. We seek to establish a long term, mutually rewarding relationship based on exclusive marketing rights business model, as well as co-marketing or strategic alliances for co-development including clinical trials of products for necessary regulatory approvals. Out-Licensing Our form ulation development expertise enables us to develop generic products which are bioequivalent. We seek out-licensing opportunities for our generic formulations for global markets.Our Global Services †¢ Formulation development †¢ Contract manufacturing of generic formulations for European market †¢ Analytical method development and validation †¢ Extensive QC capabilities (Micro, Chemical, ICH Stability) †¢ Packaging and shipping Company vision [pic] MILESTONES 1. First manufacturing operation in  Aurangabad in 1976 for tablets,  capsules and liquid orals. 2. Second unit established in  1992 at Daman  for liquid orals. 3. Third unit at  Daman established in 1998  for tablets and capsules which was later dedicated to Cephalosporin formulations. 4.Fourth unit established at  Daman in 2000  for large volume liquid orals. 5. Fifth unit established at  Daman in 2002  for tablets and capsules complying with international regulatory requirements. 6 . Medley was accredited as  ISO – 9001:2000  companies during the year 2003, by  American Quality Assessors (AQA). 7. Largest Brand R. B. Tone  is number 2 in haematinic segment as per ORG-IMS. Brand O2 launched in 2005  is number 1 in the anti diarrhoeal segment as per ORG-IMS. 8. A large manufacturing complex in  Jammu in 2005  spread over  12. 5 acres  of land. 9. State of the art  R&D centres established at Daman  which has eceived approval of Department of Science and Technology, Govt. of India in  2006. 10. Medley received the well deserved accolade  Ã¢â‚¬Å"WHO GMP Certificate†. INFRASTRUCTURE Daman Plant:- The plant is located on plot No. 18 & 19, Zari causeway road, Kachigam, Daman. This facility is located about 5 km away from Vapi railway station & about 179 km from Mumbai. The plot size is 7602 sq. mtrs, and the construction area is 7335 sq. mtrs. It has dedicated and segregated areas meeting current CGMP requirements for manufacturi ng of oral dosage forms – Tablets, Capsules & Liquid orals.Adequate areas for storage of Raw materials, Packing materials & finished products has been provided. The manufacturing capacity per annum in single shift is 5100 lac Tablets & capsules and 46 lac litres of liquid orals. The facility is WHO GMP and Schedule M GMP certified by the Indian FDA. The facility is also approved by National Drug Authority of Uganda, MOH Sudan, Tanzania, Malawi and Yemen. The Facility is MHRA-UK approved and scheduled for other highly regulated agencies MCC-SA and WHO-Geneva. Jammu Plant:- The plant is located at Lane-3, Phase I, SIDCO complex, Bari Brahman, Jammu.This facility is about 20 Kms away from the Jammu Airport. The plot size is 53115 sq. meter and total construction area is 15981 sq. meter. It has dedicated and segregated areas meeting current CGMP requirements for manufacturing of oral dosage forms – Tablets, Capsules & Liquid orals. Adequate areas for storage of Raw materia ls, Packing materials & finished products has been provided. The manufacturing capacity per annum in single shift is 8040 lac Tablets and capsules and 31. 80 lac liters of liquid orals. COMPANY PRODUCTS SUPRAKARESuprakare is the 2nd biggest division of Medley catering mainly to Orthopaedic & Gastroenterology segments. It is also the fastest growing division of Medley & has one of the most innovative and first time launches in the Indian Pharmaceutical Market like DOMPAN (Domperidone plus pantoprazole), Ostium K2 (1st brand of Vitamin K27 combination in India), Tazocef (Tazobactam plus Ceftriaxone), Acenac-N (Aceclofenac plus Pregabalin) to name a few. Today, all of them feature amongst the top 5 brands in their respective segments. Product table: Analgesic & |Analgesic & |Muscle Relaxant |Anti-Osteoporotic |Antibiotics |Digestive enzymes | |Anti-inflammatory |Antipyretic | | | | | |Acenac-P |Nimsaid-P |Colchico 4/8 Mg |Ostium K2 |Cefo L 50/100/200 |Xymex Syrup | |Acenac-SR |Nimsaid- P125/250 |Acenac-MR/Mr8 |Ostium K2 Forte |Cefo L Rediuse |Xymex MPS Tablets | | |Suspension | | | | | |Acenac-N | | | |Cefo LX 100 |Xymex Drops | |Eezflam | | | |Cefo LX 200 | | |Eezflam forte | | | |Tazocef 1. 125 | | NUTRAKARENUTRAKARE, A division of Medley Pharmaceutical is thriving since a decade and is by far the largest division of the company. Division is achieving newer heights through unique formulations & innovative ideas. Nutracare is the pioneer in Gynecology and Anti infective Segments and is known for the brands R. B Tone and O2 (First time launched in India) This features among the Top 300 Brands of Pharmaceutical Industry according to IMS ORG. †¢ O2 Tab is ranked 1st in its category in the Ofloxacin and Ornidazole Market †¢ O2 Suspension is ranked 2nd in its category in the Ofloxacin and Ornidazole Market †¢ R. B Tone is ranked 3rd in the Liquid Iron Market. Product table: Haematinics |Antibiotic Anti |Anti-ulcerants |Hepatoprotective |Antibiotics |Ant i-Cold | | |diarrhoeal | | | | | |R. B. Tone Syrup |O2 Tablets |Domrab |Trisoliv Syrup |Kefodime 50/100 DT |Oncet-CF Tablets | |R. B. Tone Capsules |O2H Tablets | | |Kefodime 200 |Oncet-CF Syrup | |R. B. Tone Forte |O2 Suspension | | |Kefodime Dry Syrup | | |R. B.Tone Drops |O2 Infusion | | |Ofoxin 200/400 | | |R. B. Tone Injection | | | |Ofoxin Suspension | | VAZOKARE Vazokare Division is catering into Life Style Segments – Cardiology and Dialectology. The division manufactures and markets the quality brands with the ultimate goal of delivering maximum possible benefits to all its customers. It also strives at its best in offering the premium quality medicines at the most economical price, thus serving the society. Vazokare proves its belief in innovation by launching the India’s first and only Glyceryl Trinitrate Spray in pen form.Our mission is to give access to the best healthcare products at the most affordable price. Product table: |Anti hypertensive |Anti-Angina l |Lipid Lowering |Anti-Diabetic |Drugs for neuropathy |Multivitamin | | | |Agent | | | | |Betabest XL 25/50 |GTN Pen |Atorin 5/10/20/40 |Gepride M1 |Mecobion P 75/150 |Mecobion OD | |Betabest AM 25 |GTN Spray |Atorin EZ |Gepride M1 |Mecobion OD | | |Encardil 2. /5/10 | |Atorin-F |Glucozid | | | |Telmed AM | | |Glucozid-M | | | |Nevol 2. 5/5 | | |Trizem 1/2 | | | NANOKARE It is the newest addition in the array of SBUs of Medley Pharmaceuticals. The Division is exploring the untapped potential to create newer horizons for the company. Medley's entry into the rural market is driven by the fact that we have a vast range of products which address disease conditions and health problems widely prevalent in rural areas.The division covers a realm of products in various therapeutic segments like anti-infective, Hematinics, anti diarrhoeal, anti ulcerants, calcium supplementation, anti cold. The Division currently is operating in Maharashtra & Madhya Pradesh, but soon has vision of spreading its tentacles pan India. Product table: |Haematinics |Analgesic and |Antibiotic |Anti-Ulecerants |Antibiotics |Multivitamin | | |Antipyretic |Antidiarrhoeal | | | | |R. B. Tone Syrup |Nimsaid-P |O2 Tablets |Dompan |Azirite 250/500 |Vistamina Tablets | |R. B.Tone Capsules |Nimsaid-P125/250 |O2H Tablets |Dompan OD |Azirite Suspension | | | |Suspension | | | | | | | |O2 Suspension | |Ofoxin 200/400 | | | | |O2 Infusion | |Cefo Suspension | | | | | | |Cefo LX 200 | | ZENKARE Within a short span of time division has made a good presence in Generic market. In Zenkare, at present, range of 300 products is available in various therapeutic segments. Introduction of new products will be done timely as per the market demand. COMPETITORS Mankind Pharma Mankind Pharma, the 8th  largest Pharmaceutical Company of India, was incepted in 1995 with a meager capital of? ?50 lakhs and 20 employees.Today, we are amongst the top 5 fastest growing Pharmaceutical companies of India with an employee base of more than 9000 and heading towards a turnover of   [pic]  2500 crores. We aspire to aid the community in leading a healthy life through two parallel objectives: formulating, developing & commercializing medicines and delivering affordable & accessible medication that satisfies urgent medical needs. Mankind is a fully integrated pharmaceutical company, with a comprehensive network of 62 C agents & 6000 Stockiest. With a pan India presence, our offerings span in Antibiotics, Antifungals, Gastrointestinals, NSAIDs, Anthelmintics, Cardiovascular, Dermal and Erectile Dysfunction categories.Our strong portfolio of businesses, geographies and products ranging from Pharma to popular OTC & FMCG brands – Unwanted72, PregaNews, Kustody, Adiction, Gas-O-Fast, Manforce Condoms and Kaloree1 provide us the strategic benefits of integration that allow us to perform best in an increasingly competitive market. With the thrust of making headway, in 2007 Mankind acquired Magnet Labs Pvt. Ltd. and marked its marketing presence in antipsychotic segment. In January 2010, Mankind acquired  Longifene, the former brand of UCB Belgium. We are further expanding the horizon of Serving Life  in Vietnam Philippines,  Myanmar and other regulated and semi-regulated markets by 2015.Today, after those tentative first steps, Mankind’s voyage is not only going strong but radiating new standards and that miniscule initial investment has grown by giant strides to crores of rupees in wealth for Mankind’s stakeholders. Having succeeded in garnering the trust of all, Mankind will continue to dream big on its path of novelty and eminence and millions of consumers will relish the results with contentment thereafter. Our Mission â€Å"To support a healthy & active lifestyle through our broad portfolio of Pharma, OTC & FMCG products† Our Vision â€Å"To be the No. 1 Pharma Company of India by 2015† 1. Mankind Pharma 2. Discovery Mankind 3. Life star Pharma 4. Special Mankind 5. Future Mankind 6.Magnet Labs Ranbaxy Pharma Ranbaxy Laboratories Limited (Ranbaxy), India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The company has a global footprint in 43 countries, world-class manufacturing facilities in 8 countries and serves customers in 125. In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd. to create an innovator and generic pharmaceutical powerhouse. The combined entity now ranks among the top 20 pharmaceutical companies, globally. The transformational deal will place Ranbaxy in a higher growth trajectory and it will emerge stronger in terms of its global reach and in its capabilit ies in drug development and manufacturing. Ranbaxy was incorporated in 1961 and went public in 1973. | | | Mission: Ranbaxy's mission is ‘enriching lives globally, with quality and affordable pharmaceuticals’. Financials: For the year 2011, the company recorded Global Sales of US $ 2. 1 Bn. The Company have a balanced mix of revenues from emerging and developed markets hat contribute 47% and 46% respectively. In 2011, North America, the company's largest market contributed sales of US $ 791 Mn, Europe contributing US $ 297 Mn and Asia clocking sales. Strategy: Ranbaxy is focused on increasing the momentum in the generics business in its key markets through organic and inorganic growth routes. Growth is well spread across geographies with focus on developed and emerging markets. It is the company's constant Endeavour to provide a wide basket of generic and innovator products, leveraging the unique Hybrid Business Model with Daiichi Sankyo. In Japan, Daiichi Sankyo Espha Co. , Ltd. (DS Espha) will market generic drugs.As part of the Hybrid Business Model, Daiichi Sankyo will utilize Ranbaxy's strong manufacturing capabilities and expertise in developing generic medicines for the Japan and market them. The company will also increasingly focus in high growth potential segments like Vaccines and Biosimilars. These new areas will add significant depth to the existing product pipeline. R: Ranbaxy views its R capabilities as a vital component of its business strategy that will provide a sustainable, long-term competitive advantage. The company has a pool of over 1000 R scientists engaged in path-breaking research. Ranbaxy is among the few Indian pharmaceutical companies in India to have started its research program in the late 70's, in support of its global ambitions. A first-of-its-kind world class R&D centre was commissioned in 1994.Today, the company has multi-disciplinary R&D centers at Gurgaon, in India, with dedicated facilities for generics researc h and innovative research. The R&D environment reflects its commitment to be a leader in the generics space offering value added formulations and development of NDA/ANDAs, based on its Novel Drug Delivery System (NDDS) research capability. Ranbaxy's first significant international success using the NDDS technology platform came in September 1999, when the company out-licensed its first once-a-day formulation. Ranbaxy has developed the anti-malarial new drug, arterolane maleate + piperaquine phosphate that has been approved by the Indian Drug Regulator, Drug Controller General of India (DCGI) for manufacturing and marketing in India.In April 2012, the company launched India's first new drug, Synriam TM, for the treatment of uncomplicated Plasmodium falciparum malaria, in adults. Within Ranbaxy, there is a sharper focus on R&D of Generics, as the company is increasingly working on more complex and specialist areas. People: The Company’s business philosophy based on delivering v alue to its stakeholders constantly inspires its people to innovate, achieve excellence and set new global benchmarks. Driven by the passion of it's over 14,000 strong multicultural work force comprising of more than 50 nationalities, Ranbaxy continues to aggressively pursue its mission of ‘Enriching lives globally, with quality and affordable pharmaceuticals'. Piramal PharmaPiramal Enterprises is the flagship company of the Piramal Group and is a world leader in its various business verticals. It has a global footprint of over 100 countries, manufacturing bases in USA, Great Britain, Sri Lanka, China and Canada and a diversified workforce representing the Piramal Group’s diversified global portfolio. Recently, the UN Conference on Trade and Development’s World Investment Report 2011 ranked Piramal Enterprises CMO (contract manufacturing) business vertical as number five in the top 10 pharmaceutical contract manufacturers worldwide; and was awarded the number one position amongst all Indian CMOs. Drug discovery and research is an important part of the business.Piramal Enterprises aspires to be the first Indian company to discover, develop and launch its own NCE drug in the global market and has made steady progress towards that goal. The company has more than 115 issued patents and 395 pending patent applications in several countries. The patents and pending applications cover a wide variety of areas across multiple discovery and development programs including compositions of matter (NCEs and natural products), methods of treatment, biomarkers, diagnostics, pharmaceutical compositions, drug delivery systems, etc. Healthcare Information Management: In May 2012, Piramal Enterprises Ltd acquired Decision Resources Group (DRG), a US based company, which is an independent provider of decision support tools, analytics and research for the global healthcare industry.Considered to offer the â€Å"Gold Standard† in analysis according to many of its clients, DRG provides web-enabled insights and predictive analytics via a variety of high value reports, databases, tools and advisory services to the global bio-pharmaceutical, managed care and med-tech industries. DRG is focused on three main market segments: (1) The Bio Pharma business unit provides reports, databases and advisory services on drug utilization trends and forecasting in a variety of therapeutic areas; (2) The Market Access business provides database and analytical services that healthcare companies use to assess the current and future opportunity of their products’ acceptance into a market. (3) The Medical Technology business provides actionable insights and data on the medical device markets.Headquartered outside of Boston, DRG has a global presence with offices in Belgium, Canada, England and Japan. Indiareit is the real estate equity funding arm. It the largest Reit fund by AUM (assets under management) in India i. e. Rs 3800 crore by June, 2011. I t has domestic and offshore funds, and has recently raised funds from UK, Singapore and Dubai. PHL Finance Pvt Ltd. is the non-banking financial company (NBFC) that has recently formed to look into funding of real estate and infrastructure projects. Cipla Pharma Cipla was established in 1935 with the vision of making India self-reliant and self-sufficient in healthcare. Today, we are one of the world’s largest generic pharmaceutical companies with a presence in over 170 countries.We are renowned for making affordable, world-class medicines that meet the needs of patients across therapies. We also offer services like consulting, commissioning, plant engineering, technical know-how transfer and support. Since inception in 1935, caring has been at the core of everything we do at Cipla. For patients, caring is a promise that we will do whatever it takes to ensure they have continued access to the highest quality medicines at affordable prices; whether a disease affects millions o r just a few hundreds. To the medical fraternity, caring means the assurance of world-class medicines and support across multiple therapeutic areas.For business partners, caring brings the confidence of always getting world-class quality and competitive prices. For employees, caring manifests itself in a safe, equal-opportunities' workplace that fosters innovation for a healthier world. History: Cipla’s journey began in 1935 when our founder, Dr. K. A. Hamied, set up an enterprise with the vision to make India self-sufficient in healthcare. Over the past 77 years, we have emerged as one of the world’s most respected pharmaceutical names, not just in India but worldwide. We have 34 state-of-the-art manufacturing facilities that make Active Pharmaceutical Ingredients (APIs) and formulations, which have been approved by major international Regulatory Agencies.We have over 2000 products in 65 therapeutic categories; with over 40 dosage forms, covering a wide spectrum of di seases ranging from communicable, non-communicable, common and emerging diseases to even rare diseases. Our Research and Development (R&D) centre is focused on developing innovative products and drug delivery systems, giving the country and the world many ‘Firsts'. Today, we are one of the world’s largest generic pharmaceutical companies with a strong presence in over 170 countries. We maintain world-class quality across all our products and services. Whether it’s for millions or for just a few hundreds, our journey to care for all humanity continues. Milestones: 1. In 1935, our founder, Dr. K. A. Hamied set up Cipla to make India self-reliant in healthcare. 2.In 1939, Mahatma Gandhi visited Cipla and inspired our founder to make essential medicines for the country, and strive for self-sufficiency. During World War II, when India was dependent on imported medicines and there was an alarming shortage of life-saving drugs, we manufactured them for the country. 3. I n the 1960s, we pioneered API manufacturing in the country and helped lay the foundation for the bulk drug industry in India. 4. In 1970, we spearheaded the New Patent Law by which an Indian pharmaceutical company was allowed to manufacture a patented product as long as the process to manufacture it was changed. This enabled Indian companies for the first time to manufacture any medicines and make them available and ffordable for all Indians. 5. In 1978, we pioneered inhalation therapy in India with the manufacture of Metered-Dose Inhaler (MDI), at a time when the country stopped receiving imported supplies. Today, we have the world’s largest range of inhaled medication and devices. 6. In 1994, we launched Deferiprone, the world’s first oral iron chelator which revolutionized the treatment for thalassemia. For the first time patients with thalassemia had an option that was affordable, painless and convenient. 7. In 1996, we gave the world the first transparent dry powd er inhaler which was so simple and easy to use, it changed the face of inhalation therapy in India. 8.In 2001, we pioneered the access to HIV treatment by making antiretrovirals (ARVs) available at less than a ‘Dollar a Day'. The cost of treatment dramatically fell from $12,000 per patient per year to $300 per patient per year. This caused a revolution where HIV treatment became a reality for the world and millions of lives could be saved. 9. During the 2005 Bird Flu epidemic, we produced an anti-flu drug within a period of 2-3 months, which would have normally taken at least 3 years to develop. 10. In 2012, we made a breakthrough in reducing the prices of cancer drugs, thus making world-class medicines affordable and accessible to cancer patients. THE SEVEN WORST MISTAKES IN PHARMA LAUNCH (AND SECRETS TO AVOID THEM)In today’s Pharma environment, the product launch period has become critical. To set up a pattern for long-term sales and profits, products must make a big splash upon their introduction. But making this happen is a process that can be filled with uncertainty, confusion and frustration. Mistakes can set back years of effort and millions of dollars in expenses. Understanding the biggest mistakes Pharma marketers can make during launch can help savvy leaders prevent catastrophes, and plot a clear path towards profit. What are the biggest mistakes Pharma marketers make during pre-launch planning, and how can they be avoided? 1. Focusing on Product, Forgetting Everything Else:Sure, a big part of launching a drug revolves around the drug itself – developing the chemical composition, submitting the drug for approval, ensuring formulary positioning, and more all focus on the physical product. But often lost in the mix is the customer and market. Long before a product is complete and ready for sale, you need a deep understanding of your customers and the market you are targeting. That means understanding, in-depth, some key points: ? Th e disease you are treating, including standards of care for that therapeutic area ? The people it affects. ? The needs of patients with the disease ? The needs of physicians treating these patients ? Key opinion leaders and professional associations in the therapeutic area ? Trends in patient access, managed care acceptance and reimbursement in the disease area Key regulatory milestones and requirements affecting the disease and the product To further know your market, you must also understand your product in terms of the competition that already exists, and that which is likely to develop before and after launch. Knowing how your product will stack up against other players in the marketplace points toward the true benefits of your drug for customers. Pre-launch planning should include some tough questions: ? How is your product better than the pharmaceuticals and intervention that already exist? ? How can an average customer, payer, physician or pharmacist differentiate between you r product and its competition? How will the product provide benefit that is different than other Pharma offerings? ? How will your competitors respond to your market entry? ? How will the competitive landscape change over time? Is this area going to explode with entries? Will generics infiltrate soon? 2. Working with the Wrong Team: A good product is important. But just as, if not more, important is the team guiding that product to market, and pushing it towards success. Instrumental in developing, marketing and selling the Pharma product is a team that boasts knowledge, experience and skills. Choosing this team is a delicate endeavor, and should combine leaders from all pay grades and units.While product managers, marketing directors and managers are often the go-to team members, chosen for their titles, successful product launches need a team with creativity, problem-solving ability and persistence, skills that can transcend titles. Businesses should therefore build launch teams b ased on experience and talent for the unique process of launch. 3. Working in Silos: For effective pre-launch planning, company departments must work together. Why is cross-functional work necessary for successful pre-launches? Consider product research and development, which can often take place in a vacuum. With a cross-functional team, R&D can learn the concerns and needs of marketers, incorporating new research points that can be instrumental in later positioning and sales.Of course, collaboration on this level can be a daunting prospect for Pharma companies, long organized by silos and strict division of tasks. Cross-functional collaboration is the pinnacle of marketing and pharmaceutical hopes, but what often happens in implementation is a crash and burn. Breaking the idea down into tactical steps, however, can ease the process from the very beginning: ? Establish and gather the pre-launch cross-functional team, including R&D, medical and regulatory affairs, and other division s of importance. For this team of leaders from these departments, the need to differentiate the ultimate product and create value must be explicitly stressed. ? Provide clear objectives for the team, as well as clearly assigned responsibilities.Everyone must understand his or her role in developing and capturing the product value. ? As key activities take place, particularly market research, review all findings with the team. ? Brainstorm and determine the needs of customers in the target area, including what is meaningful and valuable to physicians, patients and payers. ? Develop options for creating and demonstrating value to the customer base. Together, the team must brainstorm options, anticipating regulatory requirements, clinical development needs and marketing potential. Consider options also in terms of managed care organizations' perspectives, and how the company can alleviate any concerns. One collaborative partnership that is especially important to launch is that between marketing and sales. Most marketing communications people don't have a direct relationship with their sellers, and don’t understand the realities that the sellers face in everyday sales situations. Cooperative launch planning can ensure that the sales team has the pre-launch education to get new products off to a big bang, and all the materials and information they need to address target questions. 4. Rushing Launch: Everyone wants the competitive advantages of being first to the market, or first to address a unique need. But rushing product launch can come at the expense of long-term success.In attempts to speed along launch, many companies give short shrift to critical areas, and don’t try to accelerate more appropriate areas. The most-commonly skipped steps in a time crunch include primary research, business case development and cross-functional coordination, all of them crucial in best serving the market and customers. Companies can also neglect to devote enough t ime to marketing and sales tactics, brand positioning, pricing, operational support and other key decisions. Due diligence is essential in these areas, and can be tightly project-managed without losing time. An area that can be sped up rather easily, however, is one that many companies don’t think about.By investing more attention and energy into initial regulatory approval, and obtaining that approval as quickly, efficiently and comprehensively as possible, far greater value can be earned over a products life. Several regulatory means exist through which companies can look to accelerate market arrival. ? Priority Review: It offers an abbreviated priority review process for specific products that can demonstrate a key point: they serve a specific and notable unmet medical need. ? Orphan Drugs: This program offer market exclusivity for the drugs for rare diseases, but this period is offered only to the drug that receives market approval first.Applications for these orphan drug s are given greater levels of support and feedback from regulators, meaning approvals are accelerated. 5. Failure to Track, Assess and Learn: Launching a new product can be a very educational experience for all those involved. But without the means of measuring success, tracking activities, and learning from mistakes, all the lessons of launch can be forgotten, creating a missed opportunity to improve future launches. Companies should take advantage of credible metrics to measure success during the pre-launch period, and participate in a post-launch review. Companies can strengthen their processes, and set themselves up for future successes. 6. Using a One-Size-Fits-All Approach: Consistency is a critical business practice.But many companies can take this desire overboard, fitting every new product into the same mold, and eliminating the creativity and uniqueness of each product. One way to resist the cookie-cutter approach, and create a product that can be in it for long haul, is l ifecycle management. The key to better, customized product success far into the lifecycle is considering these types of strategies early, even in pre-launch. Product lifecycle management means more than plotting a counter-attack against generics. A true product lifecycle strategy is focused on maximizing the profitability of a product over its life. There are several ways to do this, and they figure prominently in the pre-launch period. Be Proactive. Start early, plan ahead, and prepare for any and all scenarios that will arise during a products life. ? Organize. Set up the cross-functional teams that will enable a comprehensive perspective and approach, whether or not these are official Lifecycle Management teams. Establish clear ownership and accountability for key actions, and defined lines of authority. More than anything, the team must include members that have the actual power and skills to drive action forward and make any necessary changes. ? Franchise Make plans for your sp ecific product, but also consider the possibilities for further expanding into the therapeutic area.A therapy franchise dominates this area through complementary products, and can be accomplished through solo efforts or licensing partnerships. ? Expand. Plan for current uses of the product, but also never stop thinking about the future uses and areas to expand into. ? Reformulate. Choose the best form of delivery that makes sense in today’s environment, but set the groundwork for new innovations. Scientists are advancing the art of formulation every day, so keep aware and keep focus on newer, patient-friendly methods of administration. Reformulation down the line is an important way of expanding a drugs usefulness and audience. ? Protect. Through the pre-launch period, the focus should be on speeding the product to approval to leverage the amount of patent exclusivity.During a products lifecycle, the team must study all regulatory trends and methods of maintaining patent prot ection. Prolonging the time before generic competition is an essential means of protecting the time and energy put into drug production. ? Switch. Think a successful OTC switch will be just the key for protection years down the line? Not without extensive planning that reaches back into the pre-launch period. Some experts contend the switch should be planned while the drug is still in clinical trials, and at a minimum of seven or eight years before action. ? Shut Down. Think you shouldn’t even consider the end of the line when you’re in pre-launch?Think again. Exit strategies should be planned and plotted. Far too often a product is allowed to limp along in its latter years, consuming valuable organizational and financial resources. Consider the long-term and the potential scenarios for actively managing the end-of-life phase, and pinpoint the cutoff point for when the product no longer delivers value. 7. Missing Out on the Secret Weapon of Analytics: No matter how muc h you plan ahead, new drug development is inherently risky in today’s environment. Increasingly, Pharma managers and marketers need a way to assess the potential of new products, and the likelihood of success upon launch.Analytics models can provide insight on what drives your target consumers, and help predict actual launch results. The Eularis Pre-Launch Analytics Systems, for example, have been implemented and worked successfully during both pre-launch and launch of numerous pharmaceutical brands. Due to effective pre-launch analytics and planning that created strong preparation for a successful launch, these products continue to be category leaders. For anyone involved in the pre-launch and lifecycle management of the product, analytics will provide significant assistance through the myriad problems and challenges that comes in this task. SWOT ANALYSIS OF MEDLEY PHARMA Strengths: 1.Strong growth in emerging market business in Suprakare division. 2. Introduction of Caramel & Zinc salt in Nutracare market that has very limited competition. 3. Co-operative and Experienced Sales team. 4. Price policy as compare to Competitors. 5. Brand value of Medley Pharma. Weakness 1. Limited presence in Indian market. 2. Weak in delivering new products in short time. 3. Lack of motivation factor among MR’s & distribution team. Opportunity 1. Capture the untapped Market 2. Can Increase their share in contract manufacturing. 3. Can improve the commission based dissatisfaction among sales team. 4. Can work on promoting brand in remote areas too. 5.Can also work on Generic market division too which is yet to launched. Threat 1. Stiff competition from many Indian and other global brands means limited market share growth. 2. Better range of new products by competitors’ at rapid speed. 3. High price & quality sensitivity of consumers. 4. Stringent patent regulations. CHAPTER: 2 RESEARCH METHODLOGY & OBJECTIVES OBJECTIVES OF THE STUDY 1. To study the possible hurdles for launching a new Pharma products. 2. To study the different competitors of Medley Pharma. 3. To study the brand value of Medley Pharma in market. 4. To study the perception and satisfaction level among Doctor’s & Druggists towards Medley Pharma. SIGNIFICANCE OF THE STUDY This research is helpful for the Medley Pharma in understanding the buying preferences of the Distributors with regard to: a) Price b) Quality c) Sales Commission ? This research is helpful for the Medley Pharma in understanding the role of the Advertising in establishing the market of the product. ? This research also helpful for Medley Pharma to improve their Distribution model. RESEARCH METHODOLOGY Research methodology is a way to systematically solve the researcher’s problem or it may be understood as a science of studying how research is done scientifically. It defines various steps that are adopted by a researcher in studying his research problem along with logic behind them. ? Steps t o be followed for Research process:- ? SAMPLING AND SAMPLE DESIGN:- SAMPLING:Sampling can be defined as the selection of some part of an aggregate or totality on the basis of which a judgment or inference about the aggregate or totality is made. In other words it is the process of obtaining information about an entire population by examining only a part of it. The process of sampling is used for various reasons- ? Sampling saves time and money. It is usually less expensive and produces results at faster speed. ? It provides more accurate information. ? It enables to estimate the sampling errors and thus assists in obtaining information concerning characteristics of population. ? It also enables greater speed of collection of data. The ultimate test of sample design is how well it represents the characteristics of the population it purports to represent.In measurement terms the sample must be valid which depends upon – ? Accuracy – It is the degree to which biasness is absent from the sample. ? Precision – It represents how well the sample represents the population in all respect. SAMPLE DESIGN: A sample design is a definite plan for obtaining a sample from the sampling frame. It refers to the technique or the procedure that is adopted in selecting the sampling units from which inferences about the population is drawn. Sampling design is determined before the collection of the data. Several decisions have to be taken in context to the decision about the appropriate sample selection so that accurate data is obtained and efficient results are drawn.Following questions have to be considered while sampling design:- ? What is the relevant population? ? What is the sampling frame? ? What is the type of sample? ? What sample size is needed? Sample Size: It indicates the number of individual who would be surveyed. Here the sample size is 102. Respondents: Doctors, Distributors, Retailers & Medical representatives of Medley Pharma. METHODOLOGY We we re supposed to operate from Medley Pharmaceuticals Ambala Division. We were made aware about all the products Medley was providing with a more stress on their core product Division i. e. Nutracare. Methodology – (OTJ-On the job) Methodology of the project starts with – In the first phase we are trained and they teach us different things about market. ? They provide the database of Distribution channel. ? Then after that we have to provide details of product & their USP’s. ? Then we have to visit the point to retrieve the information from the respondents. ? Maintaining records of feedback of respondent’s regular basis. Methodology – (OFTJ-Off the job) Exploratory research is a type of  research conducted because a problem has not been clearly defined. Exploratory research helps determine the best research design, data collection method and selection of subjects. Given its fundamental nature, exploratory research often concludes that a perceived  problem does not actually exist.Exploratory research often relies on secondary research such as reviewing available literature and/or data, or qualitative approaches such as informal discussions with consumers, employees, management or competitors, and more formal approaches through in-depth interviews, focus groups,  projective methods, case studies or pilot studies. The results of exploratory research are not usually useful for decision making  by them, but they can provide significant insight into a given situation. Although the results of qualitative research can give some indication as to the â€Å"why†, â€Å"how† and â€Å"when† something occurs, it cannot tell us â€Å"how often† or â€Å"how many. † Exploratory research is not typically generalized to the population at large. Exploratory Research Research is exploratory when you use no earlier model as a basis of your study. The most usual reason for using this approach is that you ha ve no other choice.Normally you would like to take an earlier theory as a support, but there perhaps is none, or all available models come from wrong contexts. Exploratory research means that hardly anything is known about the matter at the outset of  the project. You then have to begin with a rather vague impression of what you should study, and it is also impossible to make a detailed work plan in advance. Analysis in exploratory research is essentially Abstraction and Generalization: Abstraction means that you translate the empirical observations, measurements etc. into concepts; generalization means arranging the material so that it disengages from single persons, occurrences etc. and focus on those structures (in variances) that are common to all or most of the cases.According to Alasuutari, in qualitative analysis of empirical findings, you can distinguish two phases but these two overlap: †¢ Simplification of observations †¢ Interpretation of results (or â€Å"so lving the enigma†) In the simplification phase, the material is inspected from the theoretical point of view of the study project, and only the points relevant from this angle are noted. Details differing from